|
17 Sep 2025 |
Jyothy Labs
|
Consensus Share Price Target
|
324.95 |
399.38 |
- |
22.91 |
buy
|
|
|
|
|
16 May 2024
|
Jyothy Labs
|
Axis Direct
|
324.95
|
500.00
|
446.40
(-27.21%)
|
Target met |
Buy
|
|
|
With a 13% upside from the CMP, we maintain our long-term BUY rating on the stock.
|
|
09 Mar 2024
|
Jyothy Labs
|
Axis Direct
|
324.95
|
475.00
|
429.50
(-24.34%)
|
Target met |
Buy
|
|
|
We recommend a BUY rating on the stock with a TP of Rs 475/share, implying an upside of 10% from the CMP.
|
|
23 Feb 2024
|
Jyothy Labs
|
Sharekhan
|
324.95
|
590.00
|
475.65
(-31.68%)
|
Target met |
Buy
|
|
|
|
|
23 Feb 2024
|
Jyothy Labs
|
Sharekhan
|
324.95
|
590.00
|
467.05
(-30.43%)
|
Target met |
Buy
|
|
|
|
|
01 Feb 2024
|
Jyothy Labs
|
Motilal Oswal
|
324.95
|
500.00
|
508.20
(-36.06%)
|
Target met |
Neutral
|
|
|
|
|
01 Feb 2024
|
Jyothy Labs
|
Axis Direct
|
324.95
|
565.00
|
508.20
(-36.06%)
|
Target met |
Buy
|
|
|
With a 10% upside from the CMP, we maintain our long-term BUY rating on the stock.
|
|
16 Nov 2023
|
Jyothy Labs
|
Geojit BNP Paribas
|
324.95
|
405.00
|
439.20
(-26.01%)
|
Target met |
Sell
|
|
|
|
|
08 Nov 2023
|
Jyothy Labs
|
Axis Direct
|
324.95
|
450.00
|
416.50
(-21.98%)
|
Target met |
Buy
|
|
|
With a 12% upside from the CMP we maintain our long-term BUY rating on the stock.
|
|
08 Nov 2023
|
Jyothy Labs
|
ICICI Securities Limited
|
324.95
|
465.00
|
401.40
(-19.05%)
|
Target met |
Buy
|
|
|
In this analyst's 15-year sell-side career, he has witnessed many [deserving and momentum-based] rerating and derating stories. We reckon, JYL stock will continue to rerate as it reaps the gains of focused strategy and improved execution under Ms Jyothy's leadership.
|
|
07 Nov 2023
|
Jyothy Labs
|
Motilal Oswal
|
324.95
|
391.00
|
401.40
(-19.05%)
|
Target met |
Neutral
|
|
|
|